Cargando…

Cost Analysis of Different Antibiotic Brands Available in Indian Market with Reference to National List of Essential Medicines

BACKGROUND: About 60%–90% of healthcare spending in India is on medicine which is mainly out of pocket. Almost all the drugs including antibiotics are available as brands with variable cost. Indian government formulated National List of Essential Medicines (NLEM) to ensure availability of affordable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meena, Dinesh Kumar, Jayanthi, Mathaiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117914/ https://www.ncbi.nlm.nih.gov/pubmed/34035585 http://dx.doi.org/10.4103/ijcm.IJCM_296_20

Ejemplares similares

Availability of Key Essential Medicines in Public Health Facilities of South Indian Union Territory: One of the Crucial Components of Universal Health Coverage
por: Meena, Dinesh K, et al.
Publicado: (2021)

Monitoring Antibiotic Use in Public Health Care Facilities of South Indian Union Territory: A Step to Promote Rational Use of Antibiotics
por: Meena, Dinesh K, et al.
Publicado: (2021)

Wide Cost Variations Observed in Antibiotics and Analgesics Prescribed for Dental Care in India: A Price and Affordability Analysis
por: Gauthaman, Jeevitha, et al.
Publicado: (2022)

Medicine Storage and Dispensing Facilities in Public Healthcare Pharmacies of Puducherry, India
por: Meena, Dinesh K, et al.
Publicado: (2022)

60-Minute Brand Strategist: The Essential Brand Book for Marketing Professionals
por: Mootee, Idris
Publicado: (2013)

Availability of brands of six essential medicines in 124 pharmacies in Maharashtra
por: Millard, Colin, et al.
Publicado: (2018)

Use of drugs not listed in the National List of Essential Medicines: Findings from a prescription analysis by the Indian Council of Medical Research-Rational Use of Medicines Centres Network in tertiary care hospitals across India
por: Jhaj, Ratinder, et al.
Publicado: (2022)

Fluoride Concentration of Some Brands of Fermented Milks Available in the Market
por: Lodi, Carolina Simonetti, et al.
Publicado: (2011)

Post-market quality assessment of 22 ciprofloxacin brands by HPLC available in Bangladesh market
por: Shohag, Md Hasanuzzaman, et al.
Publicado: (2023)

Indian Essential Medicine List for Children: Time to Revisit
por: Singhal, Shubha, et al.
Publicado: (2023)

Brand equity and the Covid-19 stock market crash: Evidence from U.S. listed firms
por: Huang, Yuxuan, et al.
Publicado: (2021)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

A Cost Variation Analysis of Drugs Available in the Indian Market for the Management of Thromboembolic Disorders
por: Ray, Avik, et al.
Publicado: (2020)

A Cost-Variation Analysis of Drugs Available in the Indian Market for the Management of Diabetic Nephropathy
por: Advani, Manjari, et al.
Publicado: (2022)

Evaluating the bioequivalence of levetiracetam brand and generic oral tablets available in the Saudi market in vivo
por: ALRabeeah, Danah, et al.
Publicado: (2023)

Analysis of hematinic formulations available in the Indian market
por: Karelia, B. N., et al.
Publicado: (2012)

National List of Essential Medicines, 2015: Endocrinology perspective
por: Kalra, Sanjay
Publicado: (2016)

A comparison of national essential medicines lists in the Americas
por: Steiner, Liane, et al.
Publicado: (2020)

Determinations of Melamine Residue in Infant Formula Brands Available in Iran Market Using by HPLC Method
por: Maleki, Javad, et al.
Publicado: (2018)

Biologic medicine inclusion in 138 national essential medicines lists
por: Kraus, Raphaël, et al.
Publicado: (2021)

A cross-sectional study evaluating the knowledge, attitude, and practice of evidence-based medicine among resident doctors of a health-care Institution of National Importance in India
por: Prabath, Indumathi, et al.
Publicado: (2023)

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
por: Maraj, Darshanand, et al.
Publicado: (2022)

Identification of Differentially Expressed miRNA by Next Generation Sequencing in Locally Advanced Breast Cancer Patients of South Indian Origin
por: Tripathi, Shyam Kumar, et al.
Publicado: (2022)

Determination of Aflatoxin M(1) and Heavy Metals in Infant Formula Milk Brands Available in Pakistani Markets
por: Akhtar, Saeed, et al.
Publicado: (2017)

Genetic polymorphisms of multidrug and toxin extrusion proteins (MATE1 and MATE2) in South Indian population
por: Raj, Gerard Marshall, et al.
Publicado: (2017)

In vitro Comparison of Pancreatic Enzyme Preparations Available in the Indian Market
por: Shrikhande, Shailesh V, et al.
Publicado: (2021)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Estimation of Potential Availability of Essential Oil in Some Brands of Herbal Teas and Herbal Dietary Supplements
por: Kowalski, Radosław, et al.
Publicado: (2015)

Estimated costs of production and potential prices for the WHO Essential Medicines List
por: Hill, Andrew M, et al.
Publicado: (2018)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

Identifying the most effective essential medicines policies for quality use of medicines: A replicability study using three World Health Organisation data-sets
por: Holloway, Kathleen Anne, et al.
Publicado: (2020)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

A critical look at the national essential medicines list of India 2003
por: Manikandan, S
Publicado: (2010)

The national essential medicines list of India: Time to revise and purge the mistakes
por: Gitanjali, B
Publicado: (2010)

National List of Essential Medicines 2022 of India: Perspectives from Psychiatrists
por: Parmar, Arpit, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptor α and γ Gene Polymorphisms among South Indian Patients with Diabetic Dyslipidaemia
por: Bage, Isaac J., et al.
Publicado: (2023)

The influence of Medicare Part D on the list pricing of brand drugs
por: Ippolito, Benedic N., et al.
Publicado: (2023)

Impending Flop for Brand Antiretrovirals in the Emerging Markets?
por: Daniele, Dionisio, et al.
Publicado: (2008)

The Acidogenicity of Various Chocolates Available in Indian Market: A Comparative Study
por: M Hegde, Amitha, et al.
Publicado: (2009)

Customer agility, market orientation, and brand image in the context of Chinese market
por: Junfeng, Wang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vtq4p0t7aljk1ddui2req5dfg9